As a member of Medicines Australia, Pfizer is committed to being open and transparent when we provide a reportable payment or transfer of value to a healthcare professional.
Reportable payments or transfers of value are:

• Payments for the provision of services such as giving a lecture, chairing an educational meeting, providing advice as a member of an Advisory Board or as a Consultant

• Airfares, accommodation and/or conference registration fees to attend medical education as part of those services.

• For more information, visit the Medicines Australia (MA) webpage on Australian pharmaceutical companies' payments to healthcare professionals.

Pfizer has published reports in accordance with the Medicines Australia Code of Conduct, Edition 20, and Australian privacy legislation. These reports identify healthcare professionals by name. Any use or disclosure of the data by a third party is the responsibility of that third party, who must comply with the Australian Privacy Act 1988.

In addition to reporting transfers of value to healthcare professionals, Pfizer Australia publicly discloses Sponsorship of Third-Party Educational Meetings (TPS) and Grants and Donations (G&D) to Healthcare Organisations & support to Patient Organisations (PO). This information can be found at the Medicines Australia website links below.
TPS and G&D - Member Company Reports – Medicines Australia
PO - Member Company Reports – Medicines Australia

To view Pfizer’s historical reports from October 2015 – November 2018 see the right hand side of this page.  

For newer reports and searchable data from November 2018 onwards, please go to www.disclosureaustralia.com.au.

For further information about the details in the report, please go to medicinesaustralia.com.au
The historical reports from October 2015 – November 2018 are designed to be read on this website.